LGND Ligand Pharmaceuticals Incorporated
LGND Ligand Pharmaceuticals Incorporated
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $197.87 · VWAP $246.84 · +23.0% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CFO, Director + 1 other sold $12.8M, Aug 4–14
Coverage
1 watchlist
LGND Price Structure
Loading timeframes…
Peers
Every watchlist LGND belongs to, members best 30-day change first — LGND highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How LGND's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about LGND from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 10 days ago · Oct 13
- Ligand Pharmaceuticals (LGND) Q2 2026 Earnings Call Transcript & Audio
- Ligand Stock Price Today | NASDAQ: LGND Live - Investing.com
- Ligand Pharmaceuticals (LGND) Stock Price & Overview
- Ligand Pharmaceuticals Incorporated - Ligand Reports Second Quarter 2026 Financial Results
- Ligand Pharmaceuticals Incorporated TradeGate Share News (LGND)
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
LGND research tape
58 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.